Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT reports.
© 2024 TechCrunch. All rights reserved. For personal use only.
Posted from: this blog via Microsoft Power Automate.
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT reports.
© 2024 TechCrunch. All rights reserved. For personal use only.
Posted from: this blog via Microsoft Power Automate.
0 comments:
Post a Comment